PAI Partners’ Acquisition of SGD Pharma

Eight Advisory and Willkie Farr & Gallagher LLP represented PAI Partners in the transaction, while Bredin Prat and PwC Société d’Avocats advised JIC.

PAI Partners has made a binding offer for the acquisition of SGD Pharma, a leading global manufacturer of primary glass packaging for the pharmaceutical industry, to China Jianyin Investment Ltd. (JIC).

Headquartered in France, SGD Pharma employs 3,200 people worldwide, with a network of five industry-reference plants located in France, Germany, China, and India. It supplies Type I, II and III, molded and tubular, amber and flint glass packaging to a wide range of customers including international pharma laboratories, generics manufacturers, CDMOs, biotechs, and wholesalers.

Under JIC ownership, SGD Pharma has continuously invested in its industrial footprint and further accelerated its innovation efforts, strengthening its leadership and developing strong positions in attractive higher growth, as well as value, segments and geographies.

The contemplated transaction will be submitted to the relevant employee representative bodies of SGD Pharma and be subject to the finalization of the process required by the Ministry of Finance of China. The completion of the contemplated transaction would be subject to antitrust approvals.

The Eight Advisory team included Guillaume Rembry (Picture), Kevin Peau, Guillaume Exerjean, and Imane Sellam.

Bredin Prat advised JIC with Patrick Dziewolski, Thomas Priolet, Jing Wei, Margaux de Bourayne, Valentin Linares Cruz, Sébastien de Monès, Franck Morhain, Pauline Belleau, Yelena Trifounovitch, Anne Jussiaux, Romain Verzeni, Laetitia Tombarello, Emilie Gatineau, Karine Sultan, Julia Apostle, Juliette Crouzet, and Laurianne Billette.

The Willkie deal team was led by partners Christophe Garaud and Grégory de Saxcé and included associate Charlène Jouët on the corporate aspects as well as partner Faustine Viala and associates David Kupka and Maud Boukhris on the antitrust aspects of the transaction.

The PwC Société d’Avocats team included Xavier Etienne, Arielle Ohayon-Cohen, Julie Givernaud.

Involved fees earner: Julia Apostle – Bredin Prat; Pauline Belleau – Bredin Prat; Lauriane Billette – Bredin Prat; Juliette Crouzet – Bredin Prat; Margaux de Bourayne – Bredin Prat; Sébastien de Monès – Bredin Prat; Patrick Dziewolski – Bredin Prat; Emilie Gatineau – Bredin Prat; Anne Jussiaux – Bredin Prat; Valentin Linares-Cruz – Bredin Prat; Franck Morhain – Bredin Prat; Thomas Priolet – Bredin Prat; Karine Sultan – Bredin Prat; Laetitia Tombarello – Bredin Prat; Yelena Trifounovitch – Bredin Prat; Romain Verzeni – Bredin Prat; Jing Wei – Bredin Prat; Guillaume Exerjean – Eight Advisory; Kevin Peau – Eight Advisory; Guillaume Rembry – Eight Advisory; Imane Sellam – Eight Advisory; Xavier Etienne – PwC Tax & Legal; Julie Givernaud – PwC Tax & Legal; Arielle Ohayon-Cohen – PwC Tax & Legal; Maud Boukhris – Willkie Farr & Gallagher; Grégory de Saxcé – Willkie Farr & Gallagher; Christophe Garaud – Willkie Farr & Gallagher; Charlène Jouët – Willkie Farr & Gallagher; David Kupka – Willkie Farr & Gallagher; Faustine Viala – Willkie Farr & Gallagher;

Law Firms: Bredin Prat; Eight Advisory; PwC Tax & Legal; Willkie Farr & Gallagher;

Clients: China Jianyin Investment Ltd.; PAI Partners;

Author: Naoual Sadouqi

Leave a Reply